Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001415889-24-002809

CHIEF FINANCIAL OFFICER gave up 1,288 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Alam Kamran CHIEF FINANCIAL OFFICER 2024-02-02 Shares withheld for taxes −1,288 $1.51 $1,945 840,937 D
Loading xslF345X05/form4-02062024_090255.xml…